LGSLF yields 40000.00% · PFE yields 6.13%● Live data
📍 LGSLF pulled ahead of the other in Year 1
Combined, LGSLF + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LGSLF + PFE for your $10,000?
Looking Glass Labs Ltd., a digital agency, engages in the design, development, and sale of non-fungible tokens (NFTs) in Canada and internationally. The company offers 3D digital assets for existing NFT communities; NFT minting services; merchandise sales; utility services; and advertising and sponsorship services, as well as creates digital assets, such as additional clothing for avatars or tools to be used by the avatars within the House of Kibaa (HOK) origins metaverse. It also offers NFT marketing, development and minting, NFT community growth and moderation, brand design and management, smart contracts and legal, and metaverse integration services. The company was formerly known as BluKnight Aquafarms Inc. and changed its name to Looking Glass Labs Ltd. in October 2021. Looking Glass Labs Ltd. was incorporated in 2015 and is headquartered in Vancouver, Canada.
Full LGSLF Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.